The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...

Please provide your email address to receive an email when new articles are posted on . Optimal duration of beta-blockers after a heart attack remains unknown. The ABYSS trial provides new insights on ...

DEAR DR. ROACH: My sister recently had chest pain during exercise and now she is on metoprolol, but the cardiologist hasn’t explained to her the reason for the medication. What could she be on the ...

Researchers estimate that over 17.9 million people globally die each year from cardiovascular diseases, such as myocardial infarction, also known as a heart attack. Now, a new study presented at the ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

Please provide your email address to receive an email when new articles are posted on . Patients who used a beta-blocker with Simbrinza had significantly delayed allergy onset, which may boost ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

London, United Kingdom – 30 August 2024: The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI ...